Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Causal relationship between the loss of RUNX3 expression and gastric cancer.

Cell | Apr 5, 2002

http://www.ncbi.nlm.nih.gov/pubmed/11955451

Runx3/Pebp2alphaC null mouse gastric mucosa exhibits hyperplasias due to stimulated proliferation and suppressed apoptosis in epithelial cells, and the cells are resistant to growth-inhibitory and apoptosis-inducing action of TGF-beta, indicating that Runx3 is a major growth regulator of gastric epithelial cells. Between 45% and 60% of human gastric cancer cells do not significantly express RUNX3 due to hemizygous deletion and hypermethylation of the RUNX3 promoter region. Tumorigenicity of human gastric cancer cell lines in nude mice was inversely related to their level of RUNX3 expression, and a mutation (R122C) occurring within the conserved Runt domain abolished the tumor-suppressive effect of RUNX3, suggesting that a lack of RUNX3 function is causally related to the genesis and progression of human gastric cancer.

Pubmed ID: 11955451 RIS Download

Mesh terms: Animals | Apoptosis | Cell Division | Cell Transformation, Neoplastic | Core Binding Factor Alpha 3 Subunit | DNA Methylation | DNA-Binding Proteins | Epithelium | Exons | Female | Gene Deletion | Gene Expression Regulation, Neoplastic | Gene Targeting | Humans | Hyperplasia | Male | Mice | Mice, Knockout | Protein Structure, Tertiary | Stomach | Stomach Neoplasms | Transcription Factors | Transforming Growth Factor beta | Tumor Cells, Cultured | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.